Atrial natriuretic factor-induced vasodepression occurs through central nervous system

Area of Science:

• Neuroscience
• Cardiovascular Physiology
• Pharmacology

Background:

• Atrial natriuretic peptide (ANP) is a hormone known for its role in cardiovascular regulation.
• The central nervous system's influence on blood pressure is complex and involves various neurotransmitter systems.

Purpose of the Study:

• To investigate the effects of ANP on blood pressure and heart rate when administered intracerebroventricularly.
• To elucidate the role of the adrenergic nervous system in mediating ANP's central cardiovascular effects.

Main Methods:

• Administration of atriopeptin III (a form of ANP) into the fourth ventricle of spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats.
• Assessment of mean arterial blood pressure (MAP) and heart rate changes.
• Pharmacological blockade of alpha 1- and alpha 2-adrenergic receptors and depletion of central catecholamines to determine interactions.

Main Results:

• ANP significantly decreased MAP in both SHR and WKY rats.
• Heart rate remained unchanged following ANP administration.
• The ANP-induced decrease in MAP was abolished by alpha 2-adrenergic antagonist yohimbine and by central catecholamine depletion.
• Alpha 1-adrenergic antagonist prazosin did not affect the ANP response.

Conclusions:

• Central administration of ANP reduces mean arterial blood pressure in rats.
• The hypotensive effect of ANP in the brain is dependent on the integrity of the central alpha 2-adrenergic system.
• ANP's central action on blood pressure does not involve significant alterations in heart rate.